A Randomized, Double-Blind, Placebo-controlled Study of Growth Hormone in the Treatment of Fibromyalgia 1 Robert M Bennett, Sharon C Clark, Jacqueline Walczyk The American Journal of Medicine Volume 104, Issue 3, Pages 227-231 (March 1998) DOI: 10.1016/S0002-9343(97)00351-3
Fig. 1 Mean IGF-1 levels in patients tested with growth hormone or placebo. The American Journal of Medicine 1998 104, 227-231DOI: (10.1016/S0002-9343(97)00351-3)
Fig. 2 Mean (SD) scores on the Fibromyalgia Impact Questionnaire (graph A) and the number of fibromyalgia tender points (graph B) in patients treated with growth hormone or placebo. Scores at 9 months are significantly different (P <0.05) in the two groups. The American Journal of Medicine 1998 104, 227-231DOI: (10.1016/S0002-9343(97)00351-3)